IRIS
LIAKOULI, Vasiliki
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.142
EU - Europa 1.181
AS - Asia 280
Totale 3.603
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.134
IE - Irlanda 575
GB - Regno Unito 222
CN - Cina 161
DE - Germania 117
GR - Grecia 107
SG - Singapore 104
IT - Italia 72
SE - Svezia 40
UA - Ucraina 23
TR - Turchia 12
CA - Canada 8
FR - Francia 6
FI - Finlandia 5
BE - Belgio 4
RU - Federazione Russa 4
IN - India 2
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
MK - Macedonia 1
PT - Portogallo 1
RO - Romania 1
Totale 3.603
Salva come PNG Salva come JPEG
Città #
Dublin 575
Chicago 533
Wilmington 441
Falls Church 338
Jacksonville 160
Princeton 105
Chandler 103
Roxbury 103
Bremen 100
Medford 70
Beijing 56
Singapore 54
Des Moines 38
Cambridge 35
Nanjing 13
Ann Arbor 12
Naples 12
Hefei 11
Caserta 9
Jinan 9
Ottawa 8
Boardman 7
Hebei 7
Ningbo 7
Tianjin 7
Ashburn 6
Kunming 6
New York 6
Shenyang 6
Bagnoli Irpino 5
Dearborn 5
Hangzhou 5
Marsico Nuovo 5
Woodbridge 5
Athens 4
Brussels 4
Kostroma 4
Mugnano di Napoli 4
Rome 4
San Mateo 4
Taizhou 4
Changsha 3
Jiaxing 3
Napoli 3
Seattle 3
Taiyuan 3
Auburn Hills 2
Catanzaro 2
Guangzhou 2
Haikou 2
London 2
Redmond 2
Redwood City 2
Shanghai 2
Amadora 1
Avellino 1
Aversa 1
Brno 1
Central District 1
Chengdu 1
Crespellano 1
Fuzhou 1
Galati 1
Grumo Appula 1
Guizhou 1
Gunzenhausen 1
Helsinki 1
Huzhou 1
Lanzhou 1
Lappeenranta 1
Los Angeles 1
Manchester 1
Nanchang 1
Norwalk 1
Quzhou 1
Rockville 1
Sammamish 1
San Severo 1
Shaoxing 1
Skopje 1
Torre Dei Passeri 1
Wuhan 1
Xiangfen 1
Yicheng 1
Zhengzhou 1
Totale 2.952
Salva come PNG Salva come JPEG
Nome #
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 1.306
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 90
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population 60
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 54
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 38
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 37
Association of FASG670A gene polymorphism with systemic sclerosis. 37
Modificazioni della nitrossido-sintasi neuronale (nNOS) nella cute dei pazienti con sclerosi sistemica (SSc). 35
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 34
AB0226 Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC). 34
Angiogenic cytokines and growth factors in systemic sclerosis 33
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 33
Cardiovascular disease in primary sjögren’s syndrome 32
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION 32
AB0244 Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) 32
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 32
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 31
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 31
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 30
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 30
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 29
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 29
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome 28
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 27
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 26
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 25
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 25
IMPAIREMENT OF ENDOTHELIAL DIFFERENTIATION FROM MESENCHYMAL STEM CELLS (MSC) IN SYSTEMIC SCLEROSIS (SSC): A NEW TOOL IN PATHOGENETIC MECHANISM 25
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 24
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 24
Subclinical and clinical atherosclerosis in rheumatoid arthritis: Results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 24
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 23
AB0248 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 23
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 23
. FRI0437 Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from SSC Patients Induces an Anti Angiogenetic Effect, when Co-Cultured with Endothelial Cells. 23
Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? 23
Studio dell’espressione della chemochina SDF-1 e del suo recettore CXCR4 nella cute e nelle cellule endoteliali microvascolari di pazienti affetti da sclerosi sistemica (SSc). 22
Interleukin-33 and its receptor st2 may serve as 'alarmin' system of the progressing damage to the skin and visceral organs of systemic sclerosis (ssc) patients 22
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 22
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis 22
Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage 22
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease. 22
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 22
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) 21
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 21
Potential of stem cells in the treatment of rheumatic didease 21
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 21
Cellular players in angiogenesis during the course of systemic sclerosis 20
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 20
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 20
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implication. 20
Pigment epithelium derived factor secreted by ssc fibroblasts inhibits angio and vasculogenesis in vitro. 20
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 20
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 19
Interstitial lung disease in systemic sclerosis: current and future treatment 19
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 19
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 19
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis: pathogenetic implication. 19
SAT0191 Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren's syndrome. 19
The Vessels Contribute to Fibrosis in Systemic Sclerosis 19
Use of Rituximab in the Management of Sjögren’s Syndrome 19
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosis. 19
Endothelial Progenitor Cells (EPC) characterization in systemic sclerosis (SSc) patients. 19
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 19
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor 19
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 18
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature 18
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 18
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies 18
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients 18
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease 18
SDF-1 expression in the skin of SSc patients. 18
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 18
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 18
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 18
FAS -670 gene promoter polymorphism confers susceptibility to systemic sclerosis 18
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 18
Methotrexate: an old new drug in autoimmune disease 18
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine 18
Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma 18
Macitentan inhibits the transforming growth factor-βprofibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts. 18
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 17
Pathogenesis of the Endothelial Damage and Related Factors 17
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy 17
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI) 17
Tocilizumab for the treatment of adult-onset Still's disease: results from a case series 17
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset 16
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study 16
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients 16
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 16
Decreased expression of angiopoietin 1 on perivascular mesenchymalstemcells from SSc patients induces an anti angiogenic effect, when co-cultured with endothelial cells 16
Pigment Epithelium Derived Factor Secreted By Activated Fibroblasts Can Contribute To Impaired Angio and Vasculogenesis In Scleroderma. 16
 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 16
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 16
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 16
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 15
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 15
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 15
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist 15
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 15
Totale 3.620
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.354
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020234 0 7 1 1 8 3 115 43 33 11 10 2
2020/2021344 7 1 15 19 66 2 100 9 12 7 104 2
2021/20221.421 73 133 258 115 311 30 24 25 42 30 81 299
2022/20231.304 201 85 308 14 136 37 0 27 478 2 5 11
2023/2024337 17 9 1 6 153 8 6 12 4 7 9 105
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 3.733